ibrutinib,venetoclax
abbvie,janssen,roche
['venetoclax', ' ibru', 'lymsm']
a tale of two stories for venetoclax + ibrutinib in waldenstrom macroglobulinaemia: great and so far durable responses, but 2 deaths due to arrhythmias leading to stopping trial therapy for all #ash22 #wm #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer